C-reactive protein at pembrolizumab initiation and its trajectory from first-line chemotherapy as prognostic markers in metastatic urothelial carcinoma (YUSHIMA study)
Shugo Yajima, Soichiro Yoshida, Hiroyuki Sato, Akihiro Hirakawa et autres
0 citationsInternational Urology and Nephrology